Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.81 +0.32%
Revenue Growth %: -4.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: -4.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $15.03 billion versus the consensus estimate of $14.42 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Iran Wants To Make A Deal
- Stagwell names new CEO for Assembly agency globally and in APAC
- Iran proposes $10 billion BRICS reinsurance company
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
